Diversify Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9M Sell
117,466
-10,261
-8% -$268K 0.05% 304
2026
Q1
$3.35M Buy
127,727
+114,510
+866% +$3.05M 0.06% 255
2025
Q4
$332K Buy
13,217
+1,503
+13% +$37.9K 0.02% 515
2025
Q3
$289K Buy
11,714
+723
+7% +$17.8K 0.02% 462
2025
Q2
$271K Sell
10,991
-469
-4% -$10.9K 0.02% 472
2025
Q1
$273K Buy
11,460
+710
+7% +$18.6K 0.02% 449
2024
Q4
$287K Buy
10,750
+1,308
+14% +$35.5K 0.02% 436
2024
Q3
$272K Sell
9,442
-218
-2% -$6.36K 0.03% 416
2024
Q2
$287K Buy
+9,660
New +$266K 0.04% 362

Other funds holding PFE

Diversify Wealth Management's PFE Position: Q2 2026 in Review

Diversify Wealth Management reduced its Pfizer (PFE) stake by 8% in Q2 2026, selling an estimated $268K and leaving 117,466 shares worth $2.9M. The position accounts for 0.05% of the portfolio, ranked #304.

Diversify Wealth Management first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.35M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Diversify Wealth Management held 117,466 shares of Pfizer worth $2.9M as of Q2 2026.
  • Diversify Wealth Management sold 10,261 Pfizer shares in Q2 2026, an estimated $268K.
  • Pfizer made up 0.05% of Diversify Wealth Management's portfolio in Q2 2026, its #304 holding.
  • Diversify Wealth Management first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
  • Diversify Wealth Management's Pfizer position peaked at $3.35M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.